Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma…
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent…
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
ADIL Stock
Tag: ADIL Stock
Adial Pharmaceuticals Inc.’s (NASDAQ: ADIL) Subsidiary Purnovate Announce Positive PNV-5032 Data...
Kate Hudson
-
February 21, 2022
0
Adial Pharmaceuticals Inc. (NASDAQ: ADIL) Announce Positive PNV2 Data in Triple-Negative...
Kate Hudson
-
December 9, 2021
0
Adial Pharmaceutical Inc.’s (NASDAQ: ADIL) Subsidiary Purnovate Collaborates On Development of...
Ward Sport
-
October 8, 2021
0
Recent Post
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma...
Gavins Felicity
-
May 7, 2024
0
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a pioneer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapies, is set to...
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent...
May 2, 2024
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
May 1, 2024
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing...
May 1, 2024
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
April 30, 2024